Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Livro
|
![]() |
Drugs from discovery to approvalRick NgHoboken, N.J Wiley-Blackwell c2009Localização: CQ - Conjunto das Químicas (615.19 N576d 2009 )(Acessar) |
2 |
Material Type: Artigo
|
![]() |
Bilski blundering biotechSimmons, William JNature biotechnology, 2009-03, Vol.27 (3), p.245-248 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Change of law concerning drug trials is needed: Sweden should allow testing in unconscious patientsFagrell, Bengt ; Riddez, LouisLäkartidningen, 2009-11, Vol.106 (48), p.3217-3218 [Periódico revisado por pares]SwedenTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
The Medical Product Agency's work and economics--a commentAhlqvist Rastad, Jane ; Salmonson, TomasLäkartidningen, 2003-01, Vol.100 (5), p.345-345 [Periódico revisado por pares]SwedenTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Increased commercial financing of national Medical Product Agencies within the EURamel, BjörnLäkartidningen, 2003-01, Vol.100 (5), p.338-339 [Periódico revisado por pares]SwedenTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
FDA Approval and Regulation of Pharmaceuticals, 1983-2018Darrow, Jonathan J ; Avorn, Jerry ; Kesselheim, Aaron SJAMA : the journal of the American Medical Association, 2020-01, Vol.323 (2), p.164-176 [Periódico revisado por pares]United States: American Medical AssociationTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Progress and challenges towards targeted delivery of cancer therapeuticsRosenblum, Daniel ; Joshi, Nitin ; Tao, Wei ; Karp, Jeffrey M ; Peer, DanNature communications, 2018-04, Vol.9 (1), p.1410-12, Article 1410 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Clinical development success rates for investigational drugsHay, Michael ; Thomas, David W ; Craighead, John L ; Economides, Celia ; Rosenthal, JesseNature biotechnology, 2014-01, Vol.32 (1), p.40-51 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Assessing the Gold Standard — Lessons from the History of RCTsBothwell, Laura E ; Greene, Jeremy A ; Podolsky, Scott H ; Jones, David S Malina, DebraThe New England journal of medicine, 2016-06, Vol.374 (22), p.2175-2181 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patientsEichler, H-G ; Baird, LG ; Barker, R ; Bloechl-Daum, B ; Børlum-Kristensen, F ; Brown, J ; Chua, R ; Del Signore, S ; Dugan, U ; Ferguson, J ; Garner, S ; Goettsch, W ; Haigh, J ; Honig, P ; Hoos, A ; Huckle, P ; Kondo, T ; Le Cam, Y ; Leufkens, H ; Lim, R ; Longson, C ; Lumpkin, M ; Maraganore, J ; O'Rourke, B ; Oye, K ; Pezalla, E ; Pignatti, F ; Raine, J ; Rasi, G ; Salmonson, T ; Samaha, D ; Schneeweiss, S ; Siviero, PD ; Skinner, M ; Teagarden, JR ; Tominaga, T ; Trusheim, MR ; Tunis, S ; Unger, TF ; Vamvakas, S ; Hirsch, GClinical pharmacology and therapeutics, 2015-03, Vol.97 (3), p.234-246 [Periódico revisado por pares]United States: Blackwell Publishing LtdTexto completo disponível |